-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VEI3vTae86jZuGyBRneajVi+r78B7RYjJlxdczOFZicNWV2uqv1TWmDfpPzBsP+3 VGqdY+JaqOGnyk+p96zOog== 0000950123-03-009040.txt : 20030807 0000950123-03-009040.hdr.sgml : 20030807 20030806204128 ACCESSION NUMBER: 0000950123-03-009040 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030806 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20030807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FISHER SCIENTIFIC INTERNATIONAL INC CENTRAL INDEX KEY: 0000880430 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-PROFESSIONAL & COMMERCIAL EQUIPMENT & SUPPLIES [5040] IRS NUMBER: 020451017 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10920 FILM NUMBER: 03827518 BUSINESS ADDRESS: STREET 1: LIBERTY LANE CITY: HAMPTON STATE: NH ZIP: 03842 BUSINESS PHONE: 6039265911 MAIL ADDRESS: STREET 1: LIBERTY LANE CITY: LIBEHAMPTON STATE: NH ZIP: 03842 8-K 1 l02371e8vk.txt FORM 8-K ================================================================================ - -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 6, 2003 --------------------------- FISHER SCIENTIFIC INTERNATIONAL INC. (Exact name of registrant as specified in its charter) DELAWARE (State or other jurisdiction of incorporation) 1-10920 02-0451017 (Commission File No.) (IRS Employer Identification No.) ONE LIBERTY LANE, HAMPTON, NEW HAMPSHIRE 03842 (Address of principal executive offices) (Zip Code) (603) 926-5911 (Registrant's telephone number, including area code) - -------------------------------------------------------------------------------- ================================================================================ - -------------------------------------------------------------------------------- TABLE OF CONTENTS ----------------- Item 9. Regulation FD Disclosure - --------------------------------- Signatures - ---------- Exhibit Index - ------------- Exhibit 99.1: Press Release - ---------------------------- 2 ITEM 9. REGULATION FD DISCLOSURE. Attached hereto as Exhibit 99.1 is the registrant's press release dated August 6, 2003 announcing the pricing of $150 million of the Registrant's 8% senior subordinated notes due 2013. - -------------------------------------------------------------------------------- 3 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. FISHER SCIENTIFIC INTERNATIONAL INC. DATE: August 6, 2003 BY: /s/ Todd M. DuChene ----------------------------------- NAME: Todd M. DuChene TITLE: Vice President-General Counsel and Secretary - -------------------------------------------------------------------------------- 4 EXHIBIT INDEX EXHIBIT NUMBER DESCRIPTION - -------------- ---------------------------------------- Exhibit 99.1 Fisher Scientific International Inc.'s press release dated August 6, 2003 announcing the pricing of $150 million of the Registrant's 8% senior subordinated notes due 2013. 5 EX-99.1 3 l02371exv99w1.txt PRESS RELEASE NEWS RELEASE Media Contact: Investor Contact: Gia L. Oei, 603-929-2489 Carolyn Miller, 603-929-2381 E-mail: Gia.Oei@nh.fishersci.com E-mail: Carolyn.Miller@nh.fishersci.com FISHER SCIENTIFIC PRICES $150 MILLION NOTES OFFERING HAMPTON, N.H., Aug. 6, 2003-- Fisher Scientific International Inc. (NYSE: FSH) announced that it will sell $150 million in principal amount of 8 percent senior subordinated notes due 2013. The offering will close on August 20. Proceeds from the notes offering will be used to partially fund the acquisition of Perbio Science AB. In the event the Perbio transaction is not completed, the notes will be redeemed. The notes have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This news release shall not constitute an offer to sell or a solicitation of an offer to buy such notes in any jurisdiction in which such an offer or sale would be unlawful and is issued pursuant to Rule 135c under the Securities Act of 1933. ABOUT FISHER SCIENTIFIC INTERNATIONAL INC. - ------------------------------------------ Fisher Scientific International Inc. (NYSE: FSH) is the world leader in serving science. We enable scientific discovery and clinical-laboratory testing services by offering more than 600,000 products and services to over 350,000 customers in approximately 145 countries. As a result of our broad product offering, electronic-commerce capabilities, and integrated global logistics network, Fisher serves as a one-stop source of products, services and global solutions for many of our customers. The company primarily serves the scientific-research, clinical-laboratory and safety markets. Additional information about Fisher is available on the company's Web site at www.fisherscientific.com. This announcement includes forward-looking statements. Fisher Scientific has based these forward-looking statements on its current expectations and projections about future events. Although Fisher Scientific believes that its assumptions made in connection with the forward-looking statements are reasonable, no assurances can be given that its assumptions and expectations will prove to have been correct. These forward-looking statements are subject to various risks, uncertainties and assumptions. Fisher Scientific undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this announcement might not occur. # -----END PRIVACY-ENHANCED MESSAGE-----